CD4 and tuberculosis: Taken together, our results demonstrate an important proof of concept that KFE8-based subunit TB vaccines can effectively increase pulmonary CD4+ Trms and other effector/memory populations that recognize a targeted epitope and program multifunctional cytokine recall.